The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway
Molecular Carcinogenesis · 2024-08 · 63 (8) · 1500-1514
DOI: 10.1002/mc.23739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 15.05.2024. Verfasst von Runqi Hong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Serine Endopeptidases, Cell Proliferation, MAP Kinase Signaling System. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical System of Shanghai Minhang District, Grant Numbers: 2017MWDXK01 and 2020MWDXK02.
Abstract (Originalsprache)
The serine protease CORIN catalyzes pro‐atrial natriuretic peptide (pro‐ANP) into an active ANP and maintains homeostasis of the internal environment. However, it is unclear whether CORIN participates in the regulation of tumor progression. We analyzed the expression profile of CORIN in gastric cancer tissues (GCs) and adjacent nontumoral tissues (NTs). We investigated the prognostic value of CORIN in GC patients. We characterized the in vitro and in vivo activity of CORIN in cultured GC cells with gain‐of‐function and loss‐of‐function experiments. The underlying mechanism was explored by using bioinformatics, a signaling antibody array, and confirmative western blot analyses, as well as rescue experiments with highly selective small‐molecule inhibitors targeting the ERK1/2 MAPK signaling pathway. CORIN was upregulated in GCs than in NTs. Overexpression of CORIN was correlated with unfavorable prognoses in patients with GC. Ectopic expression of CORIN was promoted, whereas silencing of CORIN suppressed proliferation, colony formation, migration and invasion of GC cells, and tumor growth in vivo. Overexpression of CORIN‐induced epithelial‐mesenchymal transition (EMT) and activation of the ERK1/2 MAPK signaling pathway, while silencing of CORIN yielded opposite results. The in vitro tumor‐promoting potency of CORIN could be antagonized by selective inhibitors targeting the ERK1/2 MAPK pathway. In conclusion, CORIN is a potential prognostic marker and therapeutic target for GC patients, which may promote tumor progression by mediating the ERK1/2 MAPK signaling pathway and EMT in GC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
- Department of Surgical Oncology, Minhang Brunch, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Animal Science, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, China.
- Department of Pathology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Runqi Hong
Förderung
- Medical System of Shanghai Minhang District, Grant Numbers: 2017MWDXK01 and 2020MWDXK02
Zitieren
APA
Hong, R., Zhang, X., Zhang, Y., Bei, L., Yang, J., Xia, J., Hu, Z., Cao, Z., Chen, R., Chen, L., Niu, G., & Ke, C. (2024). The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway. Molecular Carcinogenesis, 63(8), 1500-1514. https://doi.org/10.1002/mc.23739
Vancouver
Hong R, Zhang X, Zhang Y, Bei L, Yang J, Xia J, et al. The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway. Molecular Carcinogenesis. 2024;63(8):1500-1514. doi:10.1002/mc.23739
BibTeX
@article{Hong2024,
author = {Hong, Runqi and Zhang, Xiaotian and Zhang, Yi and Bei, Lanxin and Yang, Ju and Xia, Jie and Hu, Zhiqing and Cao, Zhipeng and Chen, Rui and Chen, Liang and Niu, Gengming and Ke, Chongwei},
title = {The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway},
journal = {Molecular Carcinogenesis},
year = {2024},
volume = {63},
number = {8},
pages = {1500--1514},
doi = {10.1002/mc.23739}
}
EUVIMED